NCT00046384View on ClinicalTrials.gov

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Bipolar I Disorder
Interventions
DRUG

aripiprazole

Trial Locations (14)

Unknown

Local Institution, Scottsdale

Local Institution, Little Rock

Local Institution, Chula Vista

Local Institution, Pico Rivera

Local Institution, Riverside

Local Institution, San Diego

Local Institution, Washington D.C.

Local Institution, Winter Park

Local Institution, Staten Island

Local Institution, Oklahoma City

Local Institution, Nashville

Local Institution, Falls Church

Local Institution, Bellevue

Local Institution, Mendoza

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00046384 - Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder | Biotech Hunter | Biotech Hunter